Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016.

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Special Committee on Aging (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2022.
Series:	S. hrg. ; 114-846
Subjects:	Prescription pricing > United States. Pharmaceutical industry > Corrupt practices > United States. Price fixing > United States. Pharmaceutical ethics > United States. Pearson, Michael, > 1959- Shkreli, Martin. Pharmaceutical ethics. Pharmaceutical industry > Corrupt practices. Prescription pricing. Price fixing. United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo185727

Description
Item Description:	"Serial No. 114-24" GPO Cataloging Record Distribution Program (CRDP).
Physical Description:	1 online resource (iii, 83 pages).